Regulation of phospholipid asymmetry in the erythrocyte membrane

Current Opinion in Hematology

Volumn 15, Issue 3, 2008, Pages 191-195

  Daleke, David L ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Asymmetry; Flippase; Floppase; Phospholipid; Scramblase

Indexed keywords

ABC TRANSPORTER; CALCIUM CHANNEL P TYPE; PHOSPHATIDYLSERINE; PHOSPHOLIPID;

BIOCHEMISTRY; CARDIOVASCULAR DISEASE; CELL ADHESION; DIABETES MELLITUS; ERYTHROCYTE ADHESIVENESS; ERYTHROCYTE MEMBRANE; HYPERGLYCEMIA; LIPID TRANSPORT; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEOMICS; REVIEW; SICKLE CELL ANEMIA;

ERYTHROCYTE MEMBRANE; HUMANS; LIPID BILAYERS; PHOSPHOLIPID TRANSFER PROTEINS; PHOSPHOLIPIDS; PROTEOMICS;

EID: 41949133917     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e3282f97af7     Document Type: Review

References (40)

1. Yawata Y. Cell membrane: the red blood cell as a model. Weinheim: Wiley-VCH; 2003.
2. Daleke DL. Phospholipid flippases. J Biol Chem 2007; 282:821-825. • This brief mini-review provides a summary of all classes of lipid transporters.
3. Lenoir G, Williamson P, Holthuis JC. On the origin of lipid asymmetry: the flip side of ion transport. Curr Opin Chem Biol 2007; 11:654-661. This is a good review of the current status of knowledge of the P4-ATPase family and offers a theory of how P4-ATPases might transport lipids.
4. van Meer G, Halter D, Sprong H, et al. ABC lipid transporters: extruders, flippases, or flopless activators? FEBS Lett 2006; 580:1171-1177.
5. Devaux PF, Lopez-Montero I, Bryde S. Proteins involved in lipid translocation in eukaryotic cells. Chem Phys Lipids 2006; 141:119-132.
6. Ikeda M, Kihara A, Igarashi Y. Lipid asymmetry of the eukaryotic plasma membrane: functions and related enzymes. Biol Pharm Bull 2006; 29:1542-1546.
7. Zwaal RFA, Comfurius P, Bevers EM. Surface exposure of phosphatidylserine in pathological cells. Cell Mol Life Sci 2005; 62:971-988.
8. Soupene E, Kuypers FA. Identification of an erythroid ATP-dependent aminophospholipid transporter. Br J Haematol 2006; 133:436-438.
9. Daleke DL, Paterson J, Venkatraman N. Identification of the human erythrocyte PS stimulated ATPase by proteomic analysis. FASEB J 2007; 21:A237-A240.
10. Hamon Y, Broccardo C, Chambenoit O, et al. ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. Nat Cell Biol 2000; 2:399-406.
11. Kamp D, Haest CW. Evidence for a role of the multidrug resistance protein (MRP) in the outward translocation of NBD-phospholipids in the erythrocyte membrane. Biochim Biophys Acta 1998; 1372:91-101.
12. 2+-dependent transbilayer movement of phospholipid. J Biol Chem 1996; 271:17205-17210.
13. Seigneuret M, Devaux PF. ATP-dependent asymmetric distribution of spin-labeled phospholipids in the erythrocyte membrane: relation to shape changes. Proc Natl Acad Sci USA 1984; 81:3751-3755.
14. Daleke DL, Huestis WH. Incorporation and translocation of aminophospholipids in human erythrocytes. Biochemistry 1985; 24:2406-2416.
15. Daleke DL. Regulation of transbilayer plasma membrane phospholipid asymmetry. J Lipid Res 2003; 44:233-242.
16. Smriti, Nemergut EC, Daleke DL. ATP-dependent transport of phosphatidylserine analogues in human erythrocytes. Biochemistry 2007; 46:2249-2259. These studies report that with the exception of phosphatidylcholine, lipids of a variety of headgroup structures move across the membrane in a vanadate-sensitive and NEM-sensitive manner, criteria that have been used to characterize the phosphatidylserine-selective flippase. These results question current assumptions about the number and specificity of erythrocyte flippases.
17. Smriti S, Nemergut E, Daleke D. Phospholipid inhibitors of human erythrocyte phosphatidylserine flippase activity [abstract]. Biophys J 2007; 92:174a.
18. Daleke DL, Lyles JV. Identification and purification of aminophospholipid flippases. Biochim Biophys Acta 2000; 1486:108-127.
19. 2+-ATPase: a putative PS flippase. Methods Mol Biol 2003; 228:257-269.
20. Dolis D, Moreau C, Zachowski A, Devaux PF. Aminophospholipid translocase and proteins involved in transmembrane phospholipid traffic. Biophys Chem 1997; 68:221-231.
21. Paulusma CC, Folmer DE, Ho-Mok KS, et al. ATP8B1 requires an accessory protein for endoplasmic reticulum exit and plasma membrane lipid flippase activity. Hepatology 2008; 47:268-278. Although this report is of studies in hepatocytes, it is the first to demonstrate the role for a P4-ATPase in phosphatidylserine transport in mammalian cells and to illustrate the requirement for CDC50 partner protein for proper intracellular trafficking.
22. Paterson JK, Renkema K, Burden L, et al. Lipid specific activation of the murine P4-ATPase Atp8a1 (ATPase II). Biochemistry 2006; 45:5367-5376.
23. Sohnius A, Kamp D, Haest CW. ATP and GSH dependence of MRP1-mediated outward translocation of phospholipid analogs in the human erythrocyte membrane. Mol Membr Biol 2003; 20:299-305.
24. Alder-Baerens N, Muller P, Pohl A, et al. Headgroup-specific exposure of phospholipids in ABCA1-expressing cells. J Biol Chem 2005; 280:26321-26329.
25. Sahu SK, Gummadi SN, Manoj N, Aradhyam GK. Phospholipid scramblases: an overview. Arch Biochem Biophys 2007; 462:103-114. This recent review summarizes the current state of information about phospholipid scramblases.
26. Albrecht C, McVey JH, Elliott JI, et al. A novel missense mutation in ABCA1 results in altered protein trafficking and reduced phosphatidylserine translocation in a patient with Scott syndrome. Blood 2005; 106:542-549.
27. 2+-mediated or apoptosis induced scramblase activity or externalization of phosphatidylserine.
28. Bevers EM, Tilly RH, Senden JM, et al. Exposure of endogenous phosphatidylserine at the outer surface of stimulated platelets is reversed by restoration of aminophospholipid translocase activity. Biochemistry 1989; 28:2382-2387.
29. Truong HTN, Daleke DL, Huestis WH. Dithiothreitol stimulates the activity of the plasma-membrane aminophospholipid translocator. Biochim Biophys Acta 1993; 1150:57-62.
30. 2+-ATPase, flippase and scramblase activities in human erythrocytes. FASEB J 2001; 15:A200-A210.
31. Low TY, Seow TK, Chung MC. Separation of human erythrocyte membrane associated proteins with one-dimensional and two-dimensional gel electrophoresis followed by identification with matrix-assisted laser desorption/ionization- time of flight mass spectrometry. Proteomics 2002; 2:1229-1239.
32. Pasini EM, Kirkegaard M, Mortensen P, et al. In-depth analysis of the membrane and cytosolic proteome of red blood cells. Blood 2006; 108:791-801.
33. Goodman SR, Kurdia A, Ammann L, et al. The human red blood cell proteome and interactome. Exp Biol Med (Maywood) 2007; 232:1391-1408. An excellent summary of the proteomic studies performed to date on human erythrocytes. This review also constructs and compares interactome networks for sickle and normal erythrocytes.
34. Wu CP, Klokouzas A, Hladky SB, et al. Interactions of mefloquine with ABC proteins, MRP1 (ABCC1) and MRP4 (ABCC4) that are present in human red cell membranes. Biochem Pharmacol 2005; 70:500-510.
35. Zhou S, Zong Y, Ney PA, et al. Increased expression of the Abcg2 transporter during erythroid maturation plays a role in decreasing cellular protoporphyrin IX levels. Blood 2005; 105:2571-2576.
36. de Wolf CJ, Yamaguchi H, van der Heijden I, et al. cGMP transport by vesicles from human and mouse erythrocytes. FEBS J 2007; 274:439-450.
37. de Jong K, Kuypers FA. Sulphydryl modifications alter scramblase activity in murine sickle cell disease. Br J Haematol 2006; 133:427-432.
38. Morris CR, Suh JH, Hagar W, et al. Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease. Blood 2008; 111:402-410. This publication reports data supporting the hypothesis that oxidative damage induced in red cells depletes glutamine and glutathione levels and is correlated with pulmonary hypertension in sickle cell disease. This study has implications for the mechanisms of the effects of oxidant inducing diseases on the structure of the red cell membrane.
39. Niedowicz DM, Daleke DL. The role of oxidative stress in diabetic complications. Cell Biochem Biophys 2005; 43:289-330.
40. Nwose EU, Jelinek HF, Richards RS, Kerr PG. Erythrocyte oxidative stress in clinical management of diabetes and its cardiovascular complications. Br J Biomed Sci 2007; 64:35-43.